353 research outputs found
International network for capacity building for the control of emerging viral vector-borne zoonotic diseases : arbo-zoonet
Serological evidence of rift valley fever virus circulation in domestic cattle and african buffalo in Northern Botswana (2010–2011)
Rift Valley fever (RVF) is endemic in many countries in Sub-Saharan Africa and is responsible for severe outbreaks in livestock characterized by a sudden onset of abortions and high neonatal mortality. During the last decade, several outbreaks have occurred in Southern Africa, with a very limited number of cases reported in Botswana. To date, published information on the occurrence of RVF in wild and domestic animals from Botswana is very scarce and outdated, despite being critical to national and regional disease control. To address this gap, 863 cattle and 150 buffalo sampled at the interface between livestock areas and the Chobe National Park (CNP) and the Okavango Delta (OD) were screened for the presence of RVF virus (RVFV) neutralizing antibodies. Antibodies were detected in 5.7% (n = 863), 95% confidence intervals (CI) (4.3–7.5%) of cattle and 12.7% (n = 150), 95% CI (7.8–19.5%) of buffalo samples. The overall prevalence was significantly higher (p = 0.0016) for buffalo [12.7%] than for cattle [5.7%]. Equally, when comparing RVF seroprevalence in both wildlife areas for all pooled bovid species, it was significantly higher in CNP than in OD (9.5 vs. 4%, respectively; p = 0.0004). Our data provide the first evidence of wide circulation of RVFV in both buffalo and cattle populations in Northern Botswana and highlight the need for further epidemiological and ecological investigations on RVF at the wildlife–livestock–human interface in this region. (Résumé d'auteur
Failure to establish chronic infection of the reproductive tract of the male horse with a South African asinine strain of equine arteritis virus (EAV)
Eight sexually mature horse stallions were inoculated intranasally with a South African asinine strain of EAV, a strain that was isolated from the semen of a donkey carrier. All horses developed fever, with maximum rectal temperatures of 38,9-39,9°C recorded 3-6 d post challenge. Six horses showed very mild clinical signs of equine viral arteritis and two were asymptomatic. The virus was recovered from the nasopharynxes of six horses 2-7 d after inoculation, and from buffy-coat samples of all horses, 2- 11 d after inoculation. Seroconversion to EAV was detected on days 8 and 10 and peak serum-virusneutralizing antibody titres ranging from log₁₀ 1,2 - 1,8, on days 14-20 after challege. The titres varied from log₁₀ 0,9 - 1,2 after about 10 weeks, when the experiment was terminated. In three stallions euthanased on days 5, 7 and 9 after challenge, virus was detected inconsistently in different parts of the reproductive tract and urine. No virus was isolated from the tissues of the reproductive tract collected from stallions on days 16, 23 and 68 after challenge. Five stallions were bred to six seronegative mares between 13 and 34 d post challenge. No clinical signs of EAV were observed, and neither was seroconversion detected in any of the mares after mating. No virus was recovered from semen samples collected at the time of breeding. The results of this study demonstrated that the tissues of the reproductive tracts of the stallions did not become persistently infected with a South African asinine strain of EAV.The articles have been scanned in colour with a HP Scanjet 5590; 600dpi.
Adobe Acrobat X Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format
Rift Valley fever vector diversity and impact of meteorological and environmental factors on Culex pipiens dynamics in the Okavango Delta, Botswana
Background: In Northern Botswana, rural communities, livestock, wildlife and large numbers of mosquitoes cohabitate around permanent waters of the Okavango Delta. As in other regions of sub-Saharan Africa, Rift Valley Fever (RVF) virus is known to circulate in that area among wild and domestic animals. However, the diversity and composition of potential RVF mosquito vectors in that area are unknown as well as the climatic and ecological drivers susceptible to affect their population dynamics. Methods: Using net traps baited with carbon dioxide, monthly mosquito catches were implemented over four sites surrounding cattle corrals at the northwestern border of the Okavango Delta between 2011 and 2012. The collected mosquito species were identified and analysed for the presence of RVF virus by molecular methods. In addition, a mechanistic model was developed to assess the qualitative influence of meteorological and environmental factors such as temperature, rainfall and flooding levels, on the population dynamics of the most abundant species detected (Culex pipiens). Results: More than 25,000 mosquitoes from 32 different species were captured with an overabundance of Cx. pipiens (69,39 %), followed by Mansonia uniformis (20,67 %) and a very low detection of Aedes spp. (0.51 %). No RVF virus was detected in our mosquito pooled samples. The model fitted well the Cx. pipiens catching results (ρ = 0.94, P = 0.017). The spatial distribution of its abundance was well represented when using local rainfall and flooding measures (ρ = 1, P = 0.083). The global population dynamics were mainly influenced by temperature, but both rainfall and flooding presented a significant influence. The best and worst suitable periods for mosquito abundance were around March to May and June to October, respectively. Conclusions: Our study provides the first available data on the presence of potential RVF vectors that could contribute to the maintenance and dissemination of RVF virus in the Okavango Delta. Our model allowed us to understand the dynamics of Cx. pipiens, the most abundant vector identified in this area. Potential predictions of peaks in abundance of this vector could allow the identification of the most suitable periods for disease occurrence and provide recommendations for vectorial and disease surveillance and control strategies. (Résumé d'auteur
A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania
Rift Valley fever (RVF) is an acute arthropod-borne viral zoonotic disease primarily occurring in Africa. Since RVF-like disease was reported in Tanzania in 1930, outbreaks of the disease have been reported mainly from the eastern ecosystem of the Great Rift Valley. This cross-sectional study was carried out to describe the variation in RVF virus (RVFV) seropositivity in domestic ruminants between selected villages in the eastern and western Rift Valley ecosystems in Tanzania, and identify potential risk factors. Three study villages were purposively selected from each of the two Rift Valley ecosystems. Serum samples from randomly selected domestic ruminants (n = 1,435) were tested for the presence of specific immunoglobulin G (IgG) and M (IgM), using RVF enzyme-linked immunosorbent assay methods. Mixed effects logistic regression modelling was used to investigate the association between potential risk factors and RVFV seropositivity. The overall RVFV seroprevalence (n = 1,435) in domestic ruminants was 25.8% and species specific seroprevalence was 29.7%, 27.7% and 22.0% in sheep (n = 148), cattle (n = 756) and goats (n = 531), respectively. The odds of seropositivity were significantly higher in animals sampled from the villages in the eastern than those in the western Rift Valley ecosystem (OR = 1.88, CI: 1.41, 2.51; p<0.001), in animals sampled from villages with soils of good than those with soils of poor water holding capacity (OR = 1.97; 95% CI: 1.58, 3.02; p< 0.001), and in animals which had been introduced than in animals born within the herd (OR = 5.08, CI: 2.74, 9.44; p< 0.001). Compared with animals aged 1-2 years, those aged 3 and 4-5 years had 3.40 (CI: 2.49, 4.64; p< 0.001) and 3.31 (CI: 2.27, 4.82, p< 0.001) times the odds of seropositivity. The findings confirm exposure to RVFV in all the study villages, but with a higher prevalence in the study villages from the eastern Rift Valley ecosystem
Effect of the South African asinine-94 strain of equine arteritis virus (EAV) in pregnant donkey mares and duration of maternal immunity in foals
Clinical, virological and serological responses were investigated in five pregnant donkey mares after
experimental exposure to the South African asinine-94 strain of equine arteritis virus (EAV), and the
duration of maternal immunity to EAV was studied in their foals.
In four intranasally inoculated mares, fever with maximum rectal temperatures of 39,1-40,7°C was
recorded 2-11 d after challenge. All the inoculated mares developed mild depression, and a serous
ocular and nasal discharge; in three mares mild conjunctivitis was observed. The virus was recovered
from the nasopharynx and from buffy-coat samples of all the mares 3-10 d, and 2-16 d post
inoculation (p.i.), respectively. Seroconversion to EAV was detected on days 8- 10 p.i. Peak serum-virus-
neutralizing antibody titres of log₁₀1,8-2,4, and lgG ELISA OD values of 0,85-2,15 were recorded
2-3 weeks p.i. The in-contact (p.c.) control mare developed fever on days 15-19 post exposure,
and showed mild clinical signs of equine viral arteritis similar to those observed in the inoculated
mares. Seroconversion to EAV was detected in the p.c. mare on day 20 post exposure, and virus
was isolated from nasal swabs and blood samples collected at the time of the febrile response and
1-3 d afterwards. None of the mares aborted. After they had given normal birth 45-128 d p.i. or after
p.c. exposure, no virus could be isolated from their placentas. The concentration of EAV-neutralizing
antibody in colostrum was two to eight times higher than in serum samples collected at the time
of parturition.
All the foals born to infected mares were clinically normal at the time of birth and throughout the
subsequent 1-2 months of observation. No EAV was recovered from the bully-coat fraction of
blood samples collected at birth nor from those collected on days 1, 2 and 7 after birth. Also, no virus-serum-
neutralizing or lgG ELISA antibody to EAV was detected in sera collected immediately after
birth before the foals started nursing. The colostrum-derived maternal antibodies against EAV gradually
declined and could not be detected by either the VN test or ELISA for 2-3 months after birth.
This study demonstrates that the asinine-94 strain of EAV does not cause abortion in pregnant
donkey mares. Furthermore, no carrier state could be demonstrated in foals born to mares infected
at the time of pregnancy.The articles have been scanned in colour with a HP Scanjet 5590; 600dpi.
Adobe Acrobat X Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format
High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo
Background Factors related to the natural transmission of Ebola virus (EBOV)
to humans are still not well defined. Results of previous sero-prevalence
studies suggest that circulation of EBOV in human population is common in sub-
Saharan Africa. The Efé pygmies living in Democratic Republic of the Congo are
known to be exposed to potential risk factors of EBOV infection such as bush
meat hunting, entry into caves, and contact with bats. We studied the pygmy
population of Watsa region to determine seroprevalence to EBOV infection and
possible risks factors. Method Volunteer participants (N = 300) aged 10 years
or above were interviewed about behavior that may constitute risk factors for
transmission of EBOV, including exposures to rats, bats, monkeys and entry
into caves. Samples of venous blood were collected and tested for IgG antibody
against EBOV by enzyme-linked immunosorbent assay (ELISA). The χ2-test and
Fisher’s exact test were used for the comparison of proportions and the
Student’s t-test to compare means. The association between age group and anti-
EBOV IgG prevalence was analysed by a nonparametric test for trend. Results
The prevalence of anti-EBOV IgG was 18.7 % overall and increased significantly
with age (p = 0.023). No association was observed with exposure to risk
factors (contacts with rats, bats, monkeys, or entry into caves). Conclusions
The seroprevalence of IgG antibody to EBOV in pygmies in Watsa region is among
the highest ever reported, but it remains unclear which exposures might lead
to this high infection rate calling for further ecological and behavioural
studies
Serological evidence of equine arteritis virus in donkeys in South Africa
This paper reports the first serological evidence of exposure of donkeys to equine arteritis virus.
Seven hundred and thirty-four serum samples collected between 1989 and 1992 from donkeys in
different areas of South Africa were examined for the presence of antibodies against this virus by a
microneutralization test Seventeen percent of serum samples tested positive. The distribution of
seropositive animals varied from none in the western Cape Province and the Transvaal Highveld to
30% in the northern Transvaal. The country-wide distribution of serologically positive donkeys
suggests a longstanding presence of the virus in South Africa.The articles have been scanned in colour with a HP Scanjet 5590; 600dpi.
Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.mn201
Prevalence of antibodies against some equine viruses in zebra (Zebra burchelli) in the Kruger National Park, 1991-1992
The presence of antibodies against equine encephalosis virus (EEV) and equid herpesvirus 1 and 4 in
zebra in the Kruger National Park (KNP) was demonstrated. The ability of zebra to maintain immunity
against EEV is illustrated by the appearance of neutralizing antibodies in most zebra foals within months
of losing their maternal immunity. This occurs in every month of the year, even in winter. The high
proportion of serologically positive foals in winter is ascribed to the presence of large numbers of
susceptible foals and sufficient numbers of Culicoides vectors even at that time of the year.
The high prevalence of antibodies against both herpesviruses is similar to the situation in horses and
suggests that herpesvirus infection is endemic among zebra in the KNP.
No evidence of infection with either A/equine/H3N8 or equine arteritisvirus could be found.The articles have been scanned in colour with a HP Scanjet 5590; 600dpi.
Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.mn201
Anti-Nucleocapsid Protein Immune Responses Counteract Pathogenic Effects of Rift Valley Fever Virus Infection in Mice
The known virulence factor of Rift Valley fever virus (RVFV), the NSs protein, counteracts the antiviral effects of the type I interferon response. In this study we evaluated the expression of several genes in the liver and spleen involved in innate and adaptive immunity of mice immunized with a RVFV recombinant nucleocapsid protein (recNP) combined with Alhydrogel adjuvant and control animals after challenge with wild type RVFV. Mice immunized with recNP elicited an earlier IFNβ response after challenge compared to non-immunized controls. In the acute phase of liver infection in non-immunized mice there was a massive upregulation of type I and II interferon, accompanied by high viral titers, and the up- and downregulation of several genes involved in the activation of B- and T-cells, indicating that both humoral and cellular immunity is modulated during RVFV infection. Various genes involved in pro-inflammatory responses and with pro-apoptotic effects were strongly upregulated and anti-apoptotic genes were downregulated in liver of non-immunized mice. Expression of many genes involved in B- and T-cell immunity were downregulated in spleen of non-immunized mice but normal in immunized mice. A strong bias towards apoptosis and inflammation in non-immunized mice at an acute stage of liver infection associated with suppression of several genes involved in activation of humoral and cellular immunity in spleen, suggests that RVFV evades the host immune response in more ways than only by inhibition of type I interferon, and that immunopathology of the liver plays a crucial role in RVF disease progression
- …
